Classys Recognized as a Global Leader in Medical Aesthetics with Impressive Growth Metrics

Classys Inc.: A Leader in Medical Aesthetics

Established in 2007, Classys Inc. has swiftly positioned itself as a substantial player in the global medical aesthetics market. Operating in over 80 countries, the company boasts a cumulative installation of more than 45,000 platforms. Their impressive footprint is supported by a revenue mix that sees 66% coming from international markets. With an exceptional record of executing more than 5.5 million High-Intensity Focused Ultrasound (HIFU) procedures annually, Classys continues to dominate this rapidly evolving sector.

The company’s Annual Report reveals a transformative growth trajectory, highlighting a remarkable 45% increase in revenue. This growth is coupled with significant margins exceeding 50%, signifying a robust recurring revenue model that centers around the sale of consumables used with their aesthetic devices. Indeed, consumables contribute 46% of Classys's total revenue, ensuring long-term stability and profitability.

Innovating Medical Aesthetics with Energy-Based Devices

As the global aesthetics landscape transitions, demand for energy-based treatments is on the upsurge. Classys has strategically developed its differentiated portfolio of energy-based devices (EBD) to cater to this trend. By focusing on clinical efficacy and treatment experience, the company has positioned itself favorably to meet rising consumer expectations for more natural aesthetic outcomes.

One of Classys’s flagship products, the Ultraformer, is a highly regarded HIFU device with installations in over 21,000 units worldwide. Supplementing this is the Volnewmer device, which specializes in monopolar radiofrequency treatments, further solidifying Classys's diverse offerings. This established network of product lines is pivotal as they provide seamless scalability and operational efficiency for clinics, ensuring consistency in patient outcomes as well.

Embracing a Platform Model for Recurring Revenue

Classys's business model is built around the principles of continuous device utilization, encouraging Medical Aesthetic Practices to operate their equipment efficiently. By optimizing equipment usage and placing a premium on patient satisfaction, Classys enables clinics to generate sustainable revenue streams. This reinforces a positive feedback loop where both the providers and the company benefit from the ongoing usage of consumables.

To support this recurring revenue flow, Classys has set a high standard with an operating margin exceeding 50%, a rare achievement within the medical device sector. Investors have expressed heightened interest in Classys’s unique model, which emphasizes both impressive revenue growth and sustained profitability.

Strategic Global Expansion

Classys has been making concerted efforts to enhance its global presence by transitioning from a distributor-based model to direct operations in pivotal markets such as Japan and Brazil. This strategic move allows for improved brand management and customer engagement, fostering deeper relationships and enhancing consumables penetration.

As the company looks to secure regulatory approval in China, it aims to solidify its standing across the largest medical aesthetics markets in the world, namely the United States, Europe, and China. This expansion is regarded as a critical juncture in Classys's long-term growth journey, with stakeholders recognizing the potential for significant returns.

Bright Future Ahead

As 2026 unfolds, Classys has projected a robust revenue guidance of approximately KRW 490 billion, symbolizing a significant year-on-year growth forecast of 45%. The anticipated uptick stems from direct operations in key geographic regions, alongside strong device adoption rates within Europe and the United States. Furthermore, ongoing advancements in their next-generation MRF platform signify promising growth within their technology pipeline.

Looking towards 2030, Classys’s strategy encompasses the integration of a diverse range of aesthetic energy-based devices including HIFU, MRF, and MNRF, while also venturing into dermabrasion and laser technologies. By developing a multi-device platform ecosystem, the company is equipped to deliver enhanced efficiency and scalability, positioning itself for sustained expansion in the global medical aesthetics landscape.

In summary, the trajectory of Classys Inc. in medical aesthetics is marked by remarkable growth, innovation through technology, and an unwavering commitment to quality and efficiency. Its strong foundations and strategic initiatives promise a bright future, not only for Classys but also for its partners and clients across the realm of medical aesthetics.